Moderna posts surprise quarterly profit as it eyes RSV vaccine approval —Samsung joins biosimilar race for Merck & Co.'s Keytruda blockbuster—Zimmer receives FDA clearance for robotic shoulder system--http://bit.ly/w28kSd #moderna #rsv #vaccines #merck #samsung #biosimilars #keytruda #roboticsurgery #zimmerbiomet #fda #shoulderreplacement #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma